Table 3.
Association between androgen receptor (AR) and other factors for male breast cancer
| Variable | Value | AR-positive cases | AR-negative cases | P |
| Age (years) | ≤ 65 | 6 | 2 | 0.24 |
| > 65 | 8 | 8 | ||
| Tumor size (cm) | ≤ 2 | 4 | 3 | 0.79 |
| > 2 | 9 | 8 | ||
| LN status | Positive | 6 | 4 | 0.65 |
| Negative | 4 | 5 | ||
| Grade | I | 2 | 1 | 0.73 |
| II and III | 13 | 10 | ||
| Histological type | Ductal | 15 | 10 | - |
| Lobular | 0 | 1 | ||
| ER | Positive | 12 | 10 | 0.44 |
| Negative | 3 | 1 | ||
| PR | Positive | 8 | 5 | 0.69 |
| Negative | 7 | 6 | ||
| C-erb-b2 | Positive | 9 | 8 | 0.1 |
| Negative | 6 | 3 | ||
| p53 | Positive | 1 | 0 | 0.38 |
| Negative | 14 | 11 |
ER, estrogen receptor; LN, lymph nodes; PR, progesterone receptor.